Dupuytren’s Contracture (early-stage conservative management)

Thickening of tissue in the palm, causing finger contractures.

What Is Dupuytren's Contracture?

Dupuytren's contracture is a progressive fibroproliferative disorder that affects the palmar fascia of the hand, gradually causing one or more fingers to curl inward toward the palm (Knitlova et al., 2026, Cell Mol Bioeng). The condition typically begins as a small, painless nodule in the palm and can advance over months or years into thick cords of tissue that restrict finger extension. The ring finger and little finger are most commonly affected, although any digit can be involved.

Named after the French surgeon Baron Guillaume Dupuytren, who first described a surgical treatment in 1831, the condition remains one of the most common hand disorders encountered in clinical practice. Dupuytren's contracture is not a tendon problem, as many patients initially assume; rather, it involves the fascia, a layer of connective tissue that sits between the skin and the underlying tendons and neurovascular structures. Understanding this distinction is critical because it shapes the entire treatment approach, including the important role that physiotherapy can play in early-stage management.

In its early stages, Dupuytren's contracture may respond favorably to conservative physiotherapy interventions. Larocerie-Salgado et al. (2024, J Hand Microsurg) demonstrated that the use of therapeutic splinting and soft tissue mobilization produced measurable improvements in both joint extension and the radiologic dimensions of diseased fascia, confirming that nonoperative approaches have a legitimate place in the management pathway before surgical options are considered. The condition is classified using the Tubiana staging system, where Stage 0 represents nodules without contracture, Stage 1 involves a total flexion deformity of 0 to 45 degrees, and progressively higher stages indicate greater loss of extension.

Prevalence

Dupuytren's disease is estimated to affect between 3 and 6 percent of the general population, with significantly higher prevalence in Northern European and Scandinavian communities, where rates may exceed 20 percent in older adults. Men are affected roughly six times more frequently than women, and the condition typically presents after age 50, although earlier onset is associated with a more aggressive disease course sometimes referred to as Dupuytren's diathesis.

Anatomy of the Palmar Fascia

Structure and Function of the Palmar Fascia

The palmar fascia, also called the palmar aponeurosis, is a triangular sheet of dense connective tissue that lies just beneath the skin of the palm. It fans out from the wrist, where it connects to the palmaris longus tendon (when present), and extends toward the base of each finger, dividing into longitudinal pretendinous bands, transverse fibers (the natatory ligaments), and vertical septa that anchor the skin to deeper structures.

This fascial network serves several important functions. It protects the underlying flexor tendons, nerves, and blood vessels from compressive injury. It stabilizes the skin of the palm during gripping activities, preventing the skin from sliding and improving grip efficiency. The vertical septa create compartments that house the neurovascular bundles and lumbrical muscles, providing structural organization to the hand's complex anatomy.

What Goes Wrong in Dupuytren's Disease

In Dupuytren's contracture, the normal fascial tissue undergoes a pathological transformation driven by myofibroblasts, specialized cells that combine features of fibroblasts and smooth muscle cells. Cooper et al. (2026, J Pathol) identified that Dupuytren's tissue actively synthesizes excessive type I collagen, fibronectin, and matrix metalloproteinases, with the transforming growth factor-beta (TGF-beta) signaling pathway playing a central role in driving this abnormal collagen production. Their research showed that cells derived from Dupuytren's nodules demonstrated significantly higher collagen gene expression compared to normal palmar fascia, particularly in response to TGF-beta1 stimulation.

The disease progresses through three recognized histological phases. The proliferative phase features dense myofibroblast activity and nodule formation. The involutional phase involves alignment of myofibroblasts along lines of tension, forming the characteristic cords. The residual phase shows relatively acellular, mature collagen tissue with established contracture. Understanding these phases is clinically important because conservative physiotherapy interventions are most effective during the earlier, more cellular phases when the tissue still retains plasticity.

Key Anatomical Structures Affected

The pretendinous bands that overlie the flexor tendons are among the first structures to become diseased, forming the central cord. As cords develop and shorten, they pull the metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints into flexion. The spiral cord, which wraps around the neurovascular bundle, is particularly clinically significant because it can displace the digital nerve from its normal anatomical position, placing it at risk during any intervention.

Causes and Risk Factors

Genetic Predisposition

  • Dupuytren's contracture has a strong genetic component. Family history is one of the most significant risk factors, with first-degree relatives of affected individuals carrying substantially elevated risk.
  • The condition follows an autosomal dominant inheritance pattern with variable penetrance, meaning that carrying the genetic predisposition does not guarantee disease expression.
  • Genome-wide association studies have identified multiple susceptibility loci, many of which are involved in the Wnt signaling pathway, a cellular communication system that regulates tissue growth and differentiation.

Established Risk Factors

Several modifiable and non-modifiable risk factors have been identified through epidemiological research:

  • Age and sex: Risk increases significantly after age 50, with men affected far more commonly than women. When women are affected, it tends to present later and progress more slowly.
  • Northern European ancestry: The condition is sometimes called the "Viking disease" due to its high prevalence in populations of Scandinavian descent, though it occurs in all ethnic groups.
  • Diabetes mellitus: Patients with diabetes have a three- to four-fold increased risk. Knitlova et al. (2026, Cell Mol Bioeng) noted that the fibrotic pathways activated in Dupuytren's disease share significant overlap with the metabolic dysfunction seen in diabetes, including aberrant TGF-beta signaling and extracellular matrix remodeling.
  • Smoking and alcohol use: Both are independently associated with increased risk, likely through their effects on microvascular circulation and tissue oxygenation.
  • Manual labor and vibration exposure: While the relationship between occupation and Dupuytren's remains debated, repeated hand trauma and vibration exposure may act as triggering factors in genetically predisposed individuals.
  • Other fibrotic conditions: Dupuytren's disease shares pathological features with Peyronie's disease (penile fibrosis) and Ledderhose disease (plantar fibromatosis), and these conditions frequently co-occur, suggesting a systemic fibrotic tendency.

The Role of Myofibroblast Activation

At the cellular level, the disease is driven by the inappropriate activation and persistence of myofibroblasts. In normal wound healing, myofibroblasts appear transiently to contract wound edges and produce new matrix, then undergo programmed cell death (apoptosis). In Dupuytren's disease, these cells fail to undergo apoptosis and instead continue to proliferate and produce excessive collagen. Cooper et al. (2026, J Pathol) demonstrated that this dysregulated collagen synthesis is specifically linked to TGF-beta1 signaling and that uncoupling this signaling pathway from collagen production may represent a future therapeutic target.

‍

Start Your Journey to 

‍Better Health Today

Recover faster, move better, and feel stronger with expert physiotherapy. Our team is here to guide you every step of the way.

Why Physiotherapy for Early-Stage Dupuytren's Contracture?

Not every patient with Dupuytren's contracture requires surgery. In fact, current clinical guidelines generally recommend delaying surgical intervention until a metacarpophalangeal joint contracture exceeds 30 degrees or a proximal interphalangeal joint contracture exceeds 15 to 20 degrees, as measured by the Hueston tabletop test (inability to place the palm flat on a table). This means there is a significant window during the early stages of the disease where physiotherapy can play a meaningful role in managing symptoms, slowing progression, and maintaining hand function.

Larocerie-Salgado et al. (2024, J Hand Microsurg) provided objective evidence that conservative physiotherapy produces measurable changes in diseased fascia. Using ultrasound elastography, they demonstrated that six months of therapeutic splinting and tissue mobilization not only improved active joint extension but also decreased the radiologic dimensions of the diseased fascia and altered its tissue composition. This is significant because it suggests that physiotherapy does not merely maintain range of motion passively but may actually influence the underlying disease process at the tissue level.

What Physiotherapy Can Do

A skilled physiotherapist working with early-stage Dupuytren's contracture can help patients in several ways:

  • Maintain and improve finger extension through targeted stretching and mobilization techniques
  • Reduce nodule-related discomfort using soft tissue massage, ultrasound therapy, and desensitization techniques
  • Slow progression of contracture through custom splinting programs that apply sustained low-load stretch to the affected fascia
  • Preserve grip strength and hand dexterity through functional strengthening exercises
  • Educate patients about activity modification, ergonomic considerations, and self-management strategies
  • Optimize outcomes before and after procedures when minimally invasive or surgical interventions become necessary

Physiotherapy as Part of a Multidisciplinary Approach

Babiker-Moore et al. (2026, Res Involv Engagem) emphasized the importance of integrating patient lived experience with clinical expertise when developing therapy programs for Dupuytren's. Their research demonstrated that incorporating patient perspectives into treatment planning led to more effective interventions, clearer communication, and outcome measures that better reflected real-world patient concerns. This patient-centred approach is fundamental to how physiotherapy operates at Vaughan Physiotherapy, where treatment plans are built collaboratively with each patient.

Timeline and Progression

Dupuytren's contracture is a slowly progressive condition, and its timeline varies considerably between individuals. Some patients may have stable nodules for decades without ever developing significant contracture, while others progress more rapidly.

Early phase (months to years):

  • Small, firm nodules appear in the palm, often near the base of the ring or little finger. Patients may notice skin pitting or tethering.
  • There is usually no pain, though some patients report tenderness when gripping.
  • At this stage, the condition is most amenable to physiotherapy intervention.

Intermediate phase (years):

  • Nodules enlarge and cords begin to form, connecting the palm to the affected finger. Gradual loss of finger extension develops.
  • The MCP joint is typically affected first.
  • Patients begin to notice functional limitations such as difficulty placing hands in pockets, wearing gloves, shaking hands, or washing their face.

Advanced phase (years to decades):

  • Established cords create fixed flexion contractures.
  • The PIP joint may become involved, and PIP contractures are generally more difficult to treat and carry a higher recurrence rate. Nocek et al. (2026, J Hand Surg Glob Online) found that PIP joint contractures demonstrated higher recurrence rates across all treatment modalities compared to MCP joint contractures, underscoring the importance of early intervention before the disease reaches the PIP joint.

Factors That Influence Progression Speed

Several features predict more aggressive disease progression, collectively referred to as Dupuytren's diathesis:

  • Onset before age 50
  • Bilateral hand involvement
  • Family history of Dupuytren's disease
  • Presence of ectopic fibromatosis (Garrod's pads on the knuckles, Ledderhose disease, Peyronie's disease)
  • Northern European ancestry

Patients with multiple diathesis features should be monitored more closely and may benefit from earlier and more intensive physiotherapy intervention to maximize the conservative management window.

Treatment Options

Conservative Physiotherapy Approaches

  • Custom splinting and orthosis programs:
    • Splinting is a cornerstone of conservative Dupuytren's management.
    • Static extension splints are typically worn at night to apply a sustained low-load stretch to the contracted fascia.
    • Larocerie-Salgado et al. (2024, J Hand Microsurg) demonstrated that a simple orthosis combined with soft tissue mobilization produced quantifiable improvements in both the degree of deformity and the quantity and quality of contracted fascia.
    • Dynamic splinting may also be used during the day for patients who can tolerate it, providing intermittent stretch forces that encourage tissue remodeling.
  • Manual therapy and soft tissue mobilization:
    • Hands-on techniques including deep friction massage over nodules, myofascial release, and joint mobilization help maintain tissue extensibility and reduce adhesion formation.
    • These techniques work by promoting blood flow, stimulating the breakdown of immature collagen cross-links, and maintaining the gliding surfaces between skin, fascia, and deeper structures.
  • Therapeutic exercise:
    • A graded exercise program typically includes finger extension stretches (performed gently and held for sustained periods), tendon gliding exercises to maintain differential motion between the flexor tendons and surrounding tissue, grip strengthening to preserve hand function, and functional dexterity training.
    • Exercise programs are individualized based on the stage of disease and the specific joints involved.
  • Therapeutic ultrasound and heat therapy:
    • Ultrasound and heat modalities can be used as adjuncts to increase tissue extensibility before stretching and manual therapy.
    • Heating the collagenous tissue to therapeutic temperatures temporarily reduces its viscosity and increases its responsiveness to mechanical stretch.
  • Patient education and self-management:
    • Educating patients about the nature of their condition, expected progression, and the rationale for each treatment component is essential for long-term adherence.
    • Home exercise programs, self-massage techniques, and splint wearing schedules form the backbone of day-to-day management between clinic visits.

Minimally Invasive Medical Procedures

When conservative measures are insufficient and contracture progresses beyond functional thresholds, several minimally invasive options exist:

  • Needle aponeurotomy (percutaneous needle fasciotomy):
    • A needle is used to puncture and weaken the cord, allowing it to be ruptured by extending the finger.
    • This clinic-based procedure offers rapid recovery but carries the highest recurrence rate among procedural interventions.
    • Nocek et al. (2026, J Hand Surg Glob Online) found in their systematic review of prospective data with minimum two-year follow-up that needle aponeurotomy had the highest likelihood of recurrence compared to both collagenase injection and limited fasciectomy.
  • Collagenase injection (Xiaflex):
    • An enzyme (collagenase clostridium histolyticum) is injected directly into the cord, dissolving it over 24 to 48 hours, after which the finger is manipulated into extension.
    • This offers a middle ground between needle aponeurotomy and surgery in terms of both invasiveness and recurrence rates, though availability varies by region.
  • Radiation therapy:
    • Low-dose radiotherapy applied to early-stage nodules and cords may slow disease progression.
    • This option is most appropriate for patients in the earliest stages with nodular disease and no established contracture.

Surgical Options

  • Limited fasciectomy:
    • The most common surgical procedure, involving excision of the diseased fascia through a palmar incision.
    • Nocek et al. (2026, J Hand Surg Glob Online) demonstrated that limited fasciectomy had the lowest recurrence rates among the three primary treatment modalities, particularly for MCP joint contractures.
    • However, surgery is more invasive, requires longer recovery, and carries risks including digital nerve injury, tendon damage, wound healing complications, and complex regional pain syndrome.
  • Dermofasciectomy:
    • In recurrent or aggressive disease, the diseased fascia is removed along with the overlying skin, which is replaced with a skin graft.
    • This approach has the lowest recurrence rate but is reserved for the most challenging cases.

The Role of Physiotherapy After Procedures

Regardless of which procedural or surgical intervention is performed, physiotherapy is essential for post-procedure rehabilitation. Babiker-Moore et al. (2026, Res Involv Engagem) highlighted that preoperative therapy programs developed in collaboration with patients improved overall outcomes by ensuring patients understood what to expect and were physically and psychologically prepared for recovery. Post-procedure physiotherapy typically includes wound management, edema control, scar management, progressive splinting to maintain the correction achieved, range-of-motion exercises, and gradual return to functional activities.

Prevention and Risk Reduction

Can Dupuytren's Contracture Be Prevented?

Because Dupuytren's contracture has a strong genetic basis, it cannot be entirely prevented in predisposed individuals. However, several strategies may reduce the risk of onset or slow progression:

  • Modifiable risk factor management:
    • Smoking cessation and moderating alcohol intake are the two most impactful lifestyle changes.
    • Both smoking and excessive alcohol consumption are independently associated with increased risk and faster progression, likely through their effects on tissue oxygenation and hepatic function.
  • Blood sugar control:
    • For patients with diabetes or prediabetes, maintaining optimal glycemic control may reduce the fibrotic stimulus that drives Dupuytren's.
    • The metabolic pathways linking diabetes to fibroproliferative disorders involve advanced glycation end-products (AGEs) that cross-link collagen and promote myofibroblast activation.
  • Hand care and ergonomics:
    • While the evidence linking manual labor to Dupuytren's is not definitive, patients with known risk factors should consider ergonomic modifications to reduce repetitive gripping forces, use vibration-dampening gloves when operating power tools, and avoid sustained forceful gripping activities when possible.
  • Regular monitoring:
    • Individuals with a family history of Dupuytren's disease, those who notice early nodule formation, or those with related fibrotic conditions should seek assessment from a hand therapy specialist.
    • Early identification allows for proactive management that may delay or prevent the development of significant contracture.
  • Emerging pharmacological approaches:
    • Research into antifibrotic therapies is ongoing.
    • Knitlova et al. (2026, Cell Mol Bioeng) developed a 3D in vitro model of Dupuytren's disease using decellularized pathological tissue seeded with patient-derived fibroblasts specifically to screen potential antifibrotic drugs.
    • Their platform demonstrated that minoxidil showed promise in reducing fibrotic markers, potentially opening the door to pharmacological prevention strategies in the future. Cooper et al. (2026, J Pathol) further suggested that targeting the TGF-beta1 signaling pathway could uncouple the fibrotic stimulus from collagen overproduction, representing another avenue for future preventive treatment.

Frequently Asked Questions

  • Is Dupuytren's contracture painful?
    • In most cases, Dupuytren's contracture is not a painful condition. The primary concern is loss of finger extension and the resulting functional limitations. However, some patients experience tenderness over developing nodules, particularly during gripping activities. In the early proliferative phase, nodules may be sensitive to pressure, and some patients report aching in the palm after heavy hand use. If you are experiencing significant hand pain, it is important to have a thorough assessment because the pain may be caused by a coexisting condition such as trigger finger, carpal tunnel syndrome, or osteoarthritis, which can occur alongside Dupuytren's.
  • Will my Dupuytren's contracture definitely get worse?
    • Not necessarily. The progression of Dupuytren's disease is highly variable. Some patients develop a nodule that remains stable for many years without ever forming cords or contractures. Others experience steady progression. Features associated with more aggressive progression include early onset (before age 50), bilateral involvement, family history, and the presence of Dupuytren's diathesis features. Regular monitoring by a physiotherapist or hand specialist can help track any changes and initiate treatment at the optimal time.
  • Can physiotherapy cure Dupuytren's contracture?
    • Physiotherapy cannot cure Dupuytren's contracture because the underlying genetic and cellular mechanisms that drive the disease remain present. However, physiotherapy can meaningfully slow disease progression, maintain hand function, reduce the severity of contracture, and delay or potentially avoid the need for surgical intervention. Larocerie-Salgado et al. (2024, J Hand Microsurg) demonstrated that conservative therapy using splinting and tissue mobilization produced objectively measurable improvements in both joint extension and the composition of diseased fascia, confirming that physiotherapy has real, quantifiable effects on the condition.
  • When should I consider surgery for Dupuytren's contracture?
    • Surgery is generally considered when contracture significantly impairs daily function. The traditional clinical threshold is a positive Hueston tabletop test, where you can no longer place your palm flat on a table surface. Numerically, this roughly corresponds to an MCP joint contracture exceeding 30 degrees or a PIP joint contracture exceeding 15 to 20 degrees. Your physiotherapist can help you monitor your contracture over time and refer you to a hand surgeon when the timing is appropriate. Earlier intervention at the PIP joint may be warranted because Nocek et al. (2026, J Hand Surg Glob Online) showed that PIP contractures carry higher recurrence rates regardless of treatment method.
  • How long does recovery take after Dupuytren's surgery?
    • Recovery timelines depend on the type of procedure performed. After needle aponeurotomy, most patients return to light activities within days and full activities within two to four weeks. After collagenase injection, a similar timeline applies, though swelling and bruising may persist for several weeks. After limited fasciectomy, recovery typically takes six to twelve weeks, with physiotherapy playing a crucial role in wound healing, scar management, splinting to maintain correction, and progressive return to function. Dermofasciectomy with skin grafting requires the longest recovery, often three to four months.
  • Does Dupuytren's contracture come back after treatment?
    • Recurrence is one of the most significant challenges in Dupuytren's management. Nocek et al. (2026, J Hand Surg Glob Online) conducted a systematic review of prospective data with at least two years of follow-up and found that across 1,411 patients and 1,698 treated joints, limited fasciectomy demonstrated the lowest recurrence risk, followed by collagenase injection, with needle aponeurotomy having the highest recurrence rate. Recurrence was also more common in PIP joint contractures compared to MCP joint contractures across all treatment types. Ongoing physiotherapy after any procedure helps maximize the duration of correction achieved.
  • Can I still exercise and use my hands normally with Dupuytren's contracture?
    • Absolutely. In fact, maintaining active use of your hands is important. Most patients with early-stage Dupuytren's can continue their normal activities, exercise routines, and hobbies without significant limitation. Your physiotherapist may recommend specific modifications for activities that involve sustained forceful gripping or repetitive vibration, but general hand use and exercise are encouraged. Grip strengthening, finger stretches, and functional exercises prescribed by your physiotherapist can help maintain hand function and may contribute to slowing disease progression.

Take the First Step Toward Better Hand Function

If you have noticed a lump in your palm, thickening of the skin on your hand, or difficulty fully straightening your fingers, early assessment and physiotherapy intervention can make a significant difference in managing Dupuytren's contracture and preserving your hand function.

Don't let Dupuytren’s contracture limit your activities or affect your daily life. Our experienced team is ready to help you build a strong foundation for lasting recovery.

Book Your Specialized Assessment Today: Phone: 905-669-1221 Location: 398 Steeles Ave W #201, Thornhill, ON L4J 6X3 Online Booking: www.vaughanphysiotherapy.com

Serving communities across Thornhill, Langstaff, Newtonbrook, Willowdale, North York, Markham, Richmond Hill, Concord, and North Toronto. Conveniently located in the heart of Thornhill, offering flexible scheduling to accommodate your recovery needs.

Team

No items found.

Expert Insights

Explore the latest articles written by our clinicians

No items found.